Discontinued — last reported Q2 '21
Current Assets
Net Cash Collateral Received - Derivative Instruments
Medtronic Net Cash Collateral Received - Derivative Instruments decreased by 53.9% to $125.00M in Q1 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ3 2020
Last reportedQ2 2021
How to read this metric
Higher levels indicate increased derivative activity or a shift in the net credit risk position relative to counterparties.
Detailed definition
This represents the net balance of cash received from counterparties to secure derivative positions. It acts as a buffer...
Peer comparison
Common for firms heavily involved in hedging or trading derivative instruments.
Metric ID:
net_cash_collateral_received_derivativesHistorical Data
13 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $12.00M | $0.00 | $0.00 | $1.00M | $6.00M | $0.00 | $29.00M | $92.00M | $52.00M | $271.00M | $125.00M |
| QoQ Change | — | — | — | -100.0% | — | — | +500.0% | -100.0% | — | +217.2% | -43.5% | +421.2% | -53.9% |
| YoY Change | — | — | — | — | — | — | — | -100.0% | — | >999% | — | +834.5% | — |
Range$0.00 – $271.00M
Avg YoY Growth+722.6%
Median YoY Growth+834.5%
Net Cash Collateral Received - Derivative Instruments at Other Companies
Frequently Asked Questions
- What is Medtronic's net cash collateral received - derivative instruments?
- Medtronic (MDT) reported net cash collateral received - derivative instruments of $125.00M in Q1 2025.
- What does net cash collateral received - derivative instruments mean?
- The net amount of cash held by the company as security for derivative contracts.